FAQ

We make sure the Curia app only shows data collected from reliable, validated sources. Such sources include regulatory bodies, clinical trial registries and hospital websites.

Once new treatments are approved, they will be visible in the app within 1-3 days. Clinical Trials are updated in near real-time.

All of our data is encrypted according to the highest industry encryption standards. We will not share any user data to third parties without the user’s consent.

We have different ways to make sure we keep the information in Curia as objective as possible. Treatments are sorted in alphabetic order and trials and experts are sorted by distance.

CURIA is unbiased in sourcing information, taking information from reliable official sources.

Cancer treatments approved for countries in which CURIA is available are in the app, including on and off-label therapies.

Experts available in the app are selected according to a broad range of criteria including time in practice, participation in scientific research, and institution type. The CURIA app includes oncology experts for all indications available in the app, and for all countries for which CURIA is available.

All clinical trials in phase 2 and 3 are available in the app, updated in near real-time. Some phase 1 trials are included when they are inherently combined with phase 2.

Curia is part of, hence financed by, Innoplexus AG, a German company that uses AI in life sciences.

Please submit all comments and remarks using our Contact form. We’re always happy to hear from our users and a member of our team will get back to you as soon as possible.

It can take up to 3 weeks to be matched or rejected with a clinical trial. Under My Trial Application, you’ll see a tag which shows the current status of your application. Click the tag to see a detailed time estimate for each step of your application. Has it been more than 3 weeks? Send us a message using our Contact form.

Currently, CURIA has information about breast cancer, cholangiocarcinoma, colorectal cancer, lung cancer, liver cancer, melanoma, pancreatic cancer, prostate cancer, renal cancer, ovarian cancer, gastric cancer, endometrial cancer, esophageal cancer, gallbladder cancer, soft tissue sarcoma and osteosarcoma. More cancer indications are added to the app over time.